Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial assesses the pharmacokinetics, safety, and tolerability of Upadacitinib in pediatric patients with polyarticular juvenile idiopathic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Juvenile Idiopathic Arthritis (JIA) | Phase 1 | Status: ACTIVE_NOT_RECRUITING